Phillip Bendele joined Inotiv in 2021 as senior vice president of our Boulder location. He runs all day-to-day operations of the Contract Pharmacology Research company site. He brings a unique mix of managerial and pharmaceutical industry experience developed over 20+ years. This expertise allows him to competently manage a wide range of departments, including animal health & welfare, scientific outcomes, finance, human resources, accounting, and regulatory affairs.
Before joining Inotiv, Bendele served as research assistant, study director, study monitor, chief operation officer, chief financial officer, and eventually chief executive officer at Bolder BioPATH Inc. contract research organization. There he was the principal investigator for over 3,000 in vivo models of inflammatory or autoimmune diseases. He performed tasks as varied as recruitment, financial management, and scientific direction. As such, his experience is a huge boon to the success of Inotiv in Boulder.